Cervical cancer: open trials in Japan

15 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT07216703
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Hyogo Cancer Center (Site 2118), Akashi · National Cancer Center Hospital (Site 2113), Chūō · National Hospital Organization Kyushu Cancer Center (Site 2102), Fukuoka · University of the Ryukyus Hospital (Site 2117), Ginowan · Saitama Medical University International Medical Center (Site 2106), Hidaka · Cancer Institute Hospital of JFCR (Site 2119), Koto · Kurume University Hospital (Site 2112), Kurume · The Jikei University Hospital (Site 2107), Minato · Aichi Cancer Center (Site 2114), Nagoya · Niigata Cancer Center Hospital (Site 2110), Niigata · Okayama University Hospital (Site 2101), Okayama · Osaka Prefectural Hospital Organization Osaka International Cancer Institute (Site 2111), Osaka · Gunma Prefectural Cancer Center (Site 2109), Ōta · National Hospital Organization Hokkaido Cancer Center (Site 2108), Sapporo · Keio University Hospital (Site 2103), Shinjyuku · Iwate Medical University Hospital (Site 2116), Shiwa-gun · Shizuoka Cancer Center (Site 2104), Sunto-gun, · Ehime University Hospital (Site 2105), Tōon · Kanagawa Cancer Center (Site 2121), Yokohama
Registry updated 2026-11-06
NCT05579366
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Trial Treatment · Phase 1/2 · Genmab
Hyogo Cancer Center, Akashi · Fukushima Medical University Hospital, Fukushima · Saitama Medical University International Medical Center, Hidaka · Cancer Institute Hospital of JFCR, Koto · Shizuoka Cancer Center, Nagaizumi-chō · Gunma Prefectural Cancer Center, Ōta · Sapporo Medical University Hospital, Sapporo · Keio University Hospital, Shinjuku-ku · Yamagata University Hospital, Yamagata
Registry updated 2026-11-04
NCT06400472
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Shizuoka Cancer Center, Shizuoka · National Cancer Center Hospital, Tokyo · Cancer Institute Hospital of JFCR, Tokyo
Registry updated 2026-11-04
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
National Cancer Center Hospital, Chūōku · National Cancer Center Hospital East, Kashiwa, Chiba · The Cancer Institute Hospital of JFCR, Kōtō City · Aichi Cancer Center Hospital, Nagoya
Registry updated 2026-11-04
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
National Cancer Center Hospital, Chuo Ku · National Cancer Center Hospital East (NCCHE) - Kashiwa Campus, Kashiwa · The Cancer Institute Hospital of JFCR, Koto-ku · Aichi Cancer Center Hospital, Nagoya · Kindai University Hospital, Sakai · Hokkaido University Hospital, Sapporo
Registry updated 2026-11-04
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Saitama Medical University International Medical Center, Hidaka · HAKUAIKAI Social Medical Corporation Sagara Hospital, Kagoshima · Kanagawa Cancer Center, Kanagawa · National Cancer Center Hospital East, Kashiwa-shi · NHO Shikoku Cancer Center, Matsuyama · Shizuoka Cancer Center, Nagaizumi-chō · Aichi Cancer Center Hospital, Nagoya · Kindai University Hospital, Osakasayama-Shi · Saitama Cancer Center, Saitama · National Cancer Center Hospital, Tokyo · Showa Medical University Hospital, Tokyo · Cancer Institute Hospital of JFCR, Tokyo · Yokohama City University Medical Center, Yokohama
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
National Cancer Center Hospital, Chuo Ku · National Cancer Center Hospital East, Kashiwa · The Cancer Institute Hospital of JFCR, Koto-ku · National Hospital Organization Shikoku Cancer Center, Matsuyama · Shizuoka Cancer Center, Nagaizumi-chō · Aichi Cancer Center Hospital, Nagoya · Kindai University Hospital, Ōsaka-sayama · Saitama Cancer Center, Saitama
Registry updated 2026-10-26
NCT06079671
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Trial Treatment · Phase 3 · AstraZeneca
Fukuoka · Ginowan-shi · Hidaka-shi · Kagoshima · Kōtoku · Kurume-shi · Maebashi · Matsuyama · Morioka · Nagoya · Osaka · Sapporo · Shinjuku-ku · Suita-shi · Sunto-gun · Toon-Shi
Registry updated 2026-09-30
NCT05983432
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Trial Treatment · Phase 1 · SystImmune Inc.
National Cancer Center Hospital, Chūōku
Registry updated 2026-09-21
NCT06535607
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Trial Treatment · Phase 2 · AstraZeneca
Kashiwa · Yokohama
Registry updated 2026-09-11
NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
National Cancer Center Hospital East, Kashiwa
Registry updated 2026-08-17
NCT05768139
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Eli Lilly and Company
National Hospital Organization Kyushu Cancer Center, Fukuoka · Kansai Medical University Hospital, Hirakata · The Cancer Institute Hospital of JFCR, Kōtō City · Kyoto University Hospital, Kyoto
Registry updated 2026-07-07
NCT07196033
Asian Gynecological Brachytherapy Registry in Cervical Cancer
Research · Tata Memorial Hospital
Gunma University, Maebashi · Juntendo University, Tokyo
Registry updated 2026-02-09
NCT06943521
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Tanabe Pharma America, Inc.
National Cancer Center Hospital, Chuo Ku · National Cancer Center Hospital East, City
Registry updated 2025-12-11
NCT06805864
Pembrolizumab Concurrent With and Following Carbon-ion Radiotherapy for Locally Advanced Cervical Adenocarcinoma
Trial Treatment · Phase 2 · Gunma University
Gunma University Hospital, Maebashi
Registry updated 2025-02-03

All Cervical cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error